Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: From discovery to clinical application

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 10, 2011, Pages 927-938

  Yin, Jiye ^a,b   Zhang, Jianting ^a,b  

^a Department of Pharmacology/Toxicology ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABCC1; Disease susceptibility; Drug resistance; Multidrug resistance associated protein 1; Prognosis; Single nucleotide polymorphism

Indexed keywords

ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;

ANIMAL; DRUG RESISTANCE; ENZYME SPECIFICITY; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUNG TUMOR; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SUBSTRATE SPECIFICITY;

EID: 82555193825     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.10.002     Document Type: Review

References (73)

1. Choudhuri S, Klaassen C D. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters[J]. Int J Toxicol, 2006, 25(4) : 231-259. (Pubitemid 44034685)
2. Mo W, Zhang J T. Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease [J]. Expert Opin Drug Metab Toxicol, 2009, 5(9): 1049-1063.
3. Cole S P, Bhardwaj G, Gerlach J H, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line[J]. Science, 1992, 258(5088): 1650-1654. (Pubitemid 23012438)
4. Conseil G, Deeley R G, Cole S P. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters [J]. Pharmacogenet Genomics, 2005, 15(8) :523-533. (Pubitemid 41044238)
5. Grant C E, Kurz E U, Cole S P, et al. Analysis of the intronexon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA[J]. Genomics, 1997, 45(2) : 368-378.
6. Mo W, Liu J Y, Zhang J T. Biochemistry and pharmacology of human ABCC1/MRP1 and its role in detoxification and in multidrug resistance of cancer chemotherapy in recent advances on cancer research and therapy[M]//Pestka S, Shi Y, Liu X Y. Recent advances on cancer research and therapy. Elsevier, 2011 (in press).
7. Yang Y, Chen Q, Zhang J T. Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistance-associated protein 1[J]. J Biol Chem, 2002, 277(46) : 44268-44277. (Pubitemid 36157860)
8. Chen Q, Yang Y, Li L, et al. The amino terminus of the human multidrug resistance transporter ABCC1 has a U-shaped folding with a gating function[J]. J Biol Chem, 2006, 281 (41): 31152-31163. (Pubitemid 44582169)
9. Chen Q, Yang Y, Liu Y, et al. Cytoplasmic retraction of the amino terminus of human multidrug resistance protein 1[J]. Biochemistry, 2002, 41(29) : 9052-9062. (Pubitemid 34787262)
10. [ Hipfner D R, Deeley R G, Cole S P, et al. Structural, mechanistic and clinical aspects of MRPI [J]. Biochim biophys Acta, 1999, 1461(2): 359-376.
11. Yang Y, Mo W, Zhang J T. Role of transmembrane segment 5 and extracellular loop 3 in the homodimerization of human ABCC1[J]. Biochemistry, 2010, 49(51): 10854-10861.
12. Yang Y, Liu Y, Dong Z, et al. Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1/MRP1 [J]. J Biol Chem, 2007, 282 (12): 8821-8830. (Pubitemid 47093510)
13. [ Walker J E, Saraste M, Runswick M J, et al. Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold[J]. EMBO J, 1982, 1 (8) : 945-951.
14. Szentpétery Z, Sarkadi B, Bakos E, et al. Functional studies on the MRP1 multidrug transporter :of ABC-signature mutant variants[ J]. Anticancer Res, 2004, 24(2A) : 449-455. (Pubitemid 38623119)
15. Szentpétery Z, Kern A, Liliom K, et al. The role of the conserved glycines of ATP-binding cassette signature motifs of MRP1 in the communication between the substrate-binding site and the catalytic centers[J]. J Biol Chem, 2004, 279(40) : 41670-41678. (Pubitemid 39313612)
16. Zaman G J, Versantvoort C H, Smit J J, et al. Analysis of the expression of MRP,the gene for a new putative transmembrane drug transporter,in human multidrug resistant lung cancer cell lines[J]. Cancer Res, 1993, 53(8): 1747-1750. (Pubitemid 23127097)
17. Flens M J, Zaman G J, Van der Valk P, et al. Tissue distribution of the multidrug resistance protein [J]. Am J Pathol, 1996, 148(4): 1237-1247. (Pubitemid 26111082)
18. St-Pierre M V, Serrano M A, Macias RI, et al. Expression of members of the multidrug resistance protein family in human term placenta [J]. Am J Physiol Regul Integr Comp Physiol, 2000, 279(4) : R1495-R1503.
19. Chang X B. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1 [J]. Cancer Metastasis Rev, 2007, 26(1): 15-37.
20. Wijnholds J, deLange E C, Scheffer G L, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier [ J ]. J Clin Invest, 2000, 105(3) : 279-285. (Pubitemid 30094447)
21. Mercier C, Masseguin C, Roux F, et al. Expression of P-glycoprotein (ABCB1) and Mrpl (ABCC1) in adult rat brain:focus on astrocytes[J]. Brain Res, 2004, 1021(1) :32-40. (Pubitemid 39158654)
22. Evers R, Zaman G J, van Deemter L, et al. Basolateral locali-zation and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells[J]. J Clin Invest, 1996, 97(5): 1211-1218.
23. Roelofsen H, Vos T A, Schippers IJ, et al. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells [ J ]. Gastroenterology, 1997, 112(2): 511-521. (Pubitemid 27078838)
24. Yin J Y, Huang Q, Yang Y, et al. Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ ABCC1) polymorphisms in Chinese population [ J ]. Pharmacogenet Genomics, 2009, 19(3) : 206-216.
25. Leslie E M, Deeley R G, Cole C P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters[J]. Toxicology, 2001, 167(1); 3-23. (Pubitemid 32830943)
26. Suzuki H, Sugiyama Y. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cmoat/MRP2 [J]. Semin Liver Dis, 1998, 18(4) : 359-376. (Pubitemid 29011040)
27. Leier I, Jedlitschky G, Buchholz U, et al. Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells[J]. Eur J Biochem, 1994, 220(2); 599-606. (Pubitemid 24092829)
28. Lima J J, Zhang S, Grant A, et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma [J]. Am J Respir Crit Care Med, 2006, 173(4); 379-385. (Pubitemid 43228324)
29. Tantisira K G, Lima J, Sylvia J, et al. 5-lipoxygenase pharmacogenetics in asthma; overlap with cys-leukotriene receptor antagonist loci [J]. Pharmacogenet Genomics, 2009, 19(3): 244-247.
30. Saito S, Iida A, Sekine A, et al. Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette,subfamily C (ABCC/MRP/CFTR) [ J]. J Hum Genet, 2002, 47(4): 147-171. (Pubitemid 34496175)
31. Moriya Y, Nakamura T, Horinouchi M, et al. Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy japanese subjects[J]. Biol Pharm Bull, 2002, 25(10) : 1356-1359. (Pubitemid 39663201)
32. Oselin K, Mrozikiewicz P M, Gaikovitch E, et al. Frequency of MRP1 genetic polymorphisms and their functional significance in Caucasians : detection of a novel mutation G816a in the human MRP1 gene[J]. Eur J Clin Pharmacol, 2003, 59(4) : 347-350. (Pubitemid 37100355)
33. Fukushima-Uesaka H, Saito Y, Tohkin M, et al. Genetic variations and haplotype structures of the ABC transporter gene ABCC1 in a japanese population[ J]. Drug Metab Pharmacokinet, 2007, 22(1): 48-60.
34. Conrad S, Kauffmann H M, Ito K, et al. Identification of human multidrug resistance protein 1(MRP1) mutations and characterization of a G671V substitution[J]. J Hum Genet, 2001, 46(11): 656-663. (Pubitemid 33134743)
35. Perdu J, Germain D P. Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13. 1 and exclusion of both genes as responsible for pseudoxanthoma elasticum [J]. Hum Mutat, 2001, 17(1): 74-75.
36. Wang H, Hao B, Zhou K, et al. Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population : implications for pharmacogenomic association studies[J]. Ann Hum Genet, 2004, 68 (Pt 6): 563-573. (Pubitemid 40028442)
37. Ito S, Ieiri I, Tanabe M, et al. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cmoat, in healthy japanese subjects[ J]. Pharmacogenetics, 2001, 11(2); 175-184. (Pubitemid 32216128)
38. Wang Z, Sew P H, Ambrose H, et al. Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region[J]. BMC Genomics, 2006, 7: 111.
39. Létourneau I J, Deeley R G, Cole S P. Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1) [J]. Pharmacogenet Genomics, 2005, 15 (9) : 647-657. (Pubitemid 41113337)
40. Leschziner G, Zabaneh D, Pirmohamed M, et al. Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance[J]. Pharmacogenet Genomics, 2006, 16(6) :439-450. (Pubitemid 43804801)
41. Wang Z, Wang B, Tang K, et al. A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection [ J ]. Hum Mol Genet, 2005, 14 (14): 2075-2087. (Pubitemid 41418043)
42. Moretti I R, Cristina A R, Sorkin S A, et al. ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment [J]. Biochem Pharmacol, 2009, 77 (1) : 66-75.
43. Mahjoubi F, Akbari S, Montazeri M, et al. MRP1 polymorphisms(T2684C, C2007T, C2012T, and C2665T) are not associated with multidrug resistance in leukemic patients[J]. Genet Mol Res, 2008, 7(4) : 1369-1374.
44. Steeghs N, Gelderblom H, Wessels J, et al. Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors[J]. Invest New Drugs, 2011, 29(1); 137-143.
45. Tanaka M, Okazaki T, Suzuki H, et al. Association of multidrug resistance gene polymorphisms with pancreatic cancer outcome[J]. Cancer, 2011, 117(4): 744-751.
46. Ranganathan P, Culverhouse R, Marsh S, et al. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in caucasian and african ameritan patients with rheumatoid arthritis[J]. J Rheumatol, 2008, 35(4) :572-579. (Pubitemid 351500051)
47. Marsh S, Paul J, King C R, et al. Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer :the scottish randomised trial in ovarian cancer [J]. J Clin Oncol, 2007, 25(29) : 4528-4535. (Pubitemid 350035308)
48. Lee S H, Lee M S, Lee J H, et al. MRP1 polymorphisms associated with citalopram response in patients with major depression[J]. J Clin Psychopharmacol, 2010, 30(2) : 116-125.
49. Warren R B, Smith R L, Campalani E, et al. Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis[ J]. J Invest Dermatol, 2008, 128 (8): 1925-1929.
50. Obata H, Yahata T, Quan J, et al. Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer[ J ]. Anticancer Res, 2006, 26(3B) : 2227-2232. (Pubitemid 43980177)
51. Siedlinski M, Boezen H M, Boer J M, et al. ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts [J]. Pharmacogenet Genomics, 2009, 19(9): 675-684.
52. Pajic M, Murray J, Marshall G M, et al. ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript[ J]. Pharmacogenet Genomics, 2011, 21 (5) : 270-279.
53. Zhao J, Yu B Y, Wang D Y, et al. Promoter polymorphism of MRPl associated with reduced survival in hepatocellular carcinoma[J]. World J Gastroenterol, 2010, 16(48); 6104-6110.
54. Innocenti F, Kroetz D L, Schuetz E, et al. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics[J]. J Clin Oncol, 2009, 27(16); 2604-2614.
55. Annemiek B, Corthals S L, Jongen L J, et al. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma : a prospective analysis of data from the hovon-65/GMMG-HD4 trial [J]. Lancet Oncol, 2010, 11(11): 1057-1065.
56. Wojnowski L, Kulle B, Schirmer M, etal. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity [ J ]. Circulation, 2005, 112(24): 3754-3762. (Pubitemid 43739516)
57. Rajagopal A, Simon S M. Subcellular localization and activity of multidrug resistance proteins[J]. Mol Biol Cell, 2003, 14 (8): 3389-3399. (Pubitemid 37013135)
58. Wang H, Jin G, Wang H, et al. Genetic susceptibility of lung cancer associated with common variants in the 3 untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1)and ABCC1 candidate transporter genes for carcinogen export[J]. Cancer, 2009, 115(3); 595-607.
59. Yin J Y, Han L F, Huang Q, et al. ABCC1 polymorphism Arg723Gln (2168G > A) is associated with lung cancer susceptibility in a Chinese population [J]. Clin Exp Pharmacol Physiol, 2011, 38(9) :632-637.
60. Mafficini A, Ortombina M, Sermet-Gaudelius I, et al. Impact of polymorphism of multidrug resistance-associated protein 1 ABCC1 gene on the severity of cystic fibrosis[J]. J Cyst Fibros, 2011, 10(4) :228-233.
61. Budulac S E, Postma D S, Hiemstra P S, et al. Multidrug resistance-associated protein-1 (MR1Pl) genetic variants, MRP1 protein levels and severity of COPD [ J ]. Respir Res, 2010, 11 : 60.
62. International HapMap Consortium. The international hapmap project[J]. Nature, 2003, 426(6968) :789-796.
63. Pennisi E. Genomics. 1000 genomes project gives new map of genetic diversity[J]. Science, 2010, 330(6004) :574-575.
64. Thomas P D, Campbell M J, Kejariwal A, et al. PANTHER; a library of protein families and subfamilies indexed by function [J]. Genome Res, 2003, 13(9); 2129-2141. (Pubitemid 37161770)
65. Ng P C, Henikoff S. Predicting deleterious amino acid substitutions[J]. Genome Res, 2001, 11(5) :863-874. (Pubitemid 32447869)
66. Pang G S, Wang J, Wang Z, et al. Predicting potentially functional SNPs in drug-response genes [J]. Pharmacogenomics, 2009, 10(4): 639-653.
67. Wang Z, Wang J, Tantoso E, et al. Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci [J]. Hum Mol Genet, 2007, 16(11): 1367-1380. (Pubitemid 47061340)
68. Bamshad M, Wooding S P. Signatures of natural selection in the human genome[J]. Nat Rev Genet, 2003, 4(2); 99-111. (Pubitemid 36150682)
69. Mishra P J, Humeniuk R, Longo-sorbello G S, et al. A miR24 microma binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance [J]. Proc Natl Acad Sci USA, 2007, 104(33) : 13513-13518. (Pubitemid 47293976)
70. Hofmann M H, Blievernicht J K, Klein K, et al. Aberrant splicing caused by single nucleotide polymorphism C516G >T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver[J].J Pharmacol Exp Ther, 2008, 325 (1) : 284-292. (Pubitemid 351439175)
71. Sharom F J. ABC multidrug transporters; structure, function and role in chemoresistance[ J]. Pharmacogenomics, 2008, 9(1); 105-127. (Pubitemid 351560534)
72. Nicolis E, Pasetto M, Cigana C, et al. The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic; a functional characterization of its relevance for cystic fibrosis [J]. BMC Med Genet, 2006, 7-7.
73. Serajee F J, Nabi R, Zhong H, et al. Polymorphisms in xenobiotic metabolism genes and autism[J]. J Child Neurol, 2004, 19(6); 413-417. (Pubitemid 39232332)